 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval4 Y# W; a+ m8 V& u; B
$ q6 t* F" b8 g& R
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
$ \7 O, Y1 z' r0 j) H' i" X. h; @ 1 s [6 S/ |3 w/ v: {9 U
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
+ q* Y4 y7 \4 o - [4 P2 A% D9 `6 ~+ k% S$ n5 l
& m' z& [2 ~/ c" M1 SEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.0 @; g: D/ i+ u# {5 b6 L
% p; {6 T# k, v$ c9 U1 rThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."/ L5 v3 |# e/ i- `& E
8 S! h# ~& N( ?1 t& m, |& e( j, lThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.; S$ }# g& i! [# n* ~" X- s7 n
, Q2 e9 j* Y- g1 S+ x X
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
9 A {8 D# Q: q. d1 z1 q1 [0 _% k- \) {+ i
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
# `- i P: m' s- k( _: a$ Z* C
" o/ f8 J8 k2 n& ^# J2 ]"As a scientist, it's one of the highlights of my CAREER," Shan said.
& Y5 J* v" w( v8 |- R. `% i0 c4 g+ j# ^# @5 o. y; J# t' T) N
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."7 j+ p! k. G) C9 X7 k" e+ K
* ~/ J+ M, s9 A( z6 Z) k M
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
$ H! P9 N: }/ }5 P! g: p# \
% L* K7 ~4 V* D: L! yGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
0 e1 n" F" y7 }% p) z+ g0 V, T- m# d c$ V( S
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.' S- a, n4 \, Y! \7 Y3 t" f
/ e' L+ x! y+ x
8 L0 b) y- E( E; l$ I6 \$ Uhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
* C' g) K# O& C2 m2 ^8 m
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
) V, K/ c7 J# b! P+ z
发表于 2015-2-28 19:45
